Moderated By: Tadsamillionaire -- (Not Moderated) -- Started: 11/8/2007 7:15:53 PM Revision History
Acusphere is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microsphere technology.
This company has been beat up and is a turn around candidate with great potential in my opinion.
This thread is for discussion of the products, outlook for partnerships, and the ability for the PPS to increase. I am long and enthusiastic about the opportunities with this company.
Acusphere Inc (ACUS ) said final late-stage trial data showed that its echocardiography imaging agent Imagify Perfusion Stress Echo, which is used to assess coronary heart disease, is well-tolerated. {Discussions for partnership ongoing}
Acusphere to Develop Potential Abraxane(R) Bioequivalent
Acusphere, Inc. (NASDAQ: ACUS - News) announced today that its product candidate AI-850 has a comparable pharmocokinetic profile to the breast cancer drug Abraxane® based upon human data available in publications on each drug. AI-850 is Acusphere’s patented formulation of paclitaxel, the active ingredient in Abraxane. {Partnership with Major Parma probable } Fast tracked! |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.